COVID-19 Patient with Encephalitis as an Initial Clinical Presentation

Creative Commons License

SARICAOĞLU E. M., ORAL M., YÖRÜK F.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, cilt.28, sa.2, ss.302-306, 2023 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 2
  • Basım Tarihi: 2023
  • Doi Numarası: 10.5578/flora.20239931
  • Dergi Adı: FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.302-306
  • Anahtar Kelimeler: Words, COVID-19, Neurological complications, Encephalitis
  • Ankara Üniversitesi Adresli: Evet

Özet

A growing number of extrapulmonary manifestations were described during COVID-19 pandemic. COVID-19 has both acute and long-term neurological complications affecting the central and peripheral nervous system. While acute encephalopathy was the most common clinically diagnosed neurological sign, the least common were meningitis and/or encephalitis. The patient was a 68-yearold previously healthy man who presented to the emergency department with symptoms of fever, headache, confusion, meaningless speech, and behavioral disorders. We present a COVID-19 patient with encephalitis as an initial clinical presentation who was treated with dexamethasone, IVIG and tocilizumab with a rapid neurological improvement. This report highlights COVID-19 encephalitis which is a rare form of the neurological involvement of COVID-19 and discusses diagnostic and therapeutic approaches.